AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (5.3 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Letter | Open Access

Renal adverse events in EGFR-TKI treatment: Comprehensive characterization of clinical patterns and molecular underpinnings

Huili Xiaoa, Anqi Lina, Wentao Xua, Junyi Shena, Cuiying Chena, Jian Zhang( ), Ting Wei( ), Peng Luo ( )
Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China

Peer review under responsibility of Chongqing Medical University.

a Huili Xiao, Anqi Lin, Wentao Xu, Junyi Shen and Cuiying Chen contributed equally to this work and shared the first authorship.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 13 Issue 4,
July 2026
DOI: 10.1016/j.gendis.2025.101953

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Xiao H, Lin A, Xu W, et al. Renal adverse events in EGFR-TKI treatment: Comprehensive characterization of clinical patterns and molecular underpinnings. Genes & Diseases, 2026, 13(4). https://doi.org/10.1016/j.gendis.2025.101953

6

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD
Received: 24 July 2025
Published: 28 November 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).